Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tissue repair and wound healing pathways encompass a coordinated sequence of cellular and molecular events designed to restore tissue integrity following injury [1]. This process is categorized into four distinct yet overlapping phases: hemostasis, inflammation, proliferation, and remodeling [2]. It involves a diverse array of cell types, including platelets, neutrophils, macrophages, fibroblasts, and endothelial cells, which communicate via complex signaling networks involving growth factors like PDGF and TGF-beta [3]. Dysregulation of these pathways is a hallmark of various pathologies, ranging from chronic non-healing ulcers in diabetic patients to excessive scarring and systemic fibrosis [1, 2]. Pharmacological intervention typically targets specific components of these pathways, such as growth factor receptors or inflammatory mediators, to promote efficient repair and minimize adverse outcomes [3].
Modulation of growth factor signaling (e.g., PDGF receptor activation), regulation of inflammatory cytokine release, enzymatic debridement of necrotic tissue, and stimulation of extracellular matrix deposition [1, 3].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tissue repair and wound healing pathways.